AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -25.0% | 245 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | +100.0% | 245 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 245 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.8% | 245 | +104.2% | 0.00% | – |
| Q3 2022 | $1,000 | – | 120 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 120 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -99.7% | 120 | -99.7% | 0.00% | -100.0% |
| Q1 2020 | $366,000 | +36500.0% | 46,100 | +20208.4% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 227 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 227 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 444,439 | $3,644,000 | 3.88% |
| Broadfin Capital, LLC | 2,591,721 | $21,252,000 | 3.47% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $13,842,000 | 1.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,955,494 | $32,435,000 | 1.28% |
| NEXTHERA CAPITAL LP | 505,921 | $4,149,000 | 0.76% |
| Perceptive Advisors | 2,391,841 | $19,613,000 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 3,308,250 | $27,128,000 | 0.55% |
| KNOTT DAVID M | 158,555 | $1,300,000 | 0.52% |
| Ativo Capital Management LLC | 130,032 | $1,066,000 | 0.28% |
| Tekla Capital Management LLC | 624,288 | $5,119,000 | 0.20% |